You are on page 1of 1

5

FDA Medical Device


Regulation
Barry Sall

CONTENTS
Introduction ....................................................................................................... 126
Is It a Device? ................................................................................................... 128
Product Jurisdiction...................................................................................... 128
Types of Medical Devices ............................................................................ 129
Medical Device Classification .......................................................................... 129
Determining Device Classification............................................................... 130
Reclassification ............................................................................................ 132
An Introduction to the MedicalDevice Approval Process................................ 135
Strategic Choices .......................................................................................... 135
Modification of Marketed Devices ............................................................... 136
Design Controls ................................................................................................ 137
The Difference between Research and Development .................................. 137
Design Control Components ........................................................................ 138
Medical Device Clinical Research .....................................................................141
Exempted Studies ......................................................................................... 142
Nonsignificant Risk Studies ......................................................................... 142
Significant Risk Studies ............................................................................... 144
The Investigational Device Exemption ........................................................ 144
Unique Aspects of Medical Device Studies ................................................. 144
The 510(k) Premarket Notification ................................................................... 146
Substantial Equivalence ................................................................................147
Types of 510(k)s ........................................................................................... 148
Traditional 510(k).................................................................................... 148
Abbreviated 510(k).................................................................................. 148
Special 510(k).......................................................................................... 150
De Novo 510(k) ....................................................................................... 150
510(k) Components ...................................................................................... 150
The Cover Sheet (Form FDA 3514) ........................................................ 150
The Cover Letter...................................................................................... 150
The Table of Contents ............................................................................. 151
User Fee Information............................................................................... 151
Form FDA 3654 ...................................................................................... 151
Statement of Substantial Equivalence ..................................................... 151
125

You might also like